Ocrelizumab IV administration has taken four or five hours but injections will make ‘significant difference’
Thousands of people with multiple sclerosis in England are to benefit from a 10-minute injection that cuts the time they need to spend in hospital by more than 90%.
At the moment, patients taking the drug ocrelizumab (Ocrevus) require twice-yearly intravenous infusions, which can take four or five hours or more to administer every time they are in hospital.
Continue reading…Ocrelizumab IV administration has taken four or five hours but injections will make ‘significant difference’Thousands of people with multiple sclerosis in England are to benefit from a 10-minute injection that cuts the time they need to spend in hospital by more than 90%.At the moment, patients taking the drug ocrelizumab (Ocrevus) require twice-yearly intravenous infusions, which can take four or five hours or more to administer every time they are in hospital. Continue reading…